Surgical treatment of gastrointestinal stromal tumor in the esophagus: Report of three cases

Zeitschrift fur Gastroenterologie

Volumn 45, Issue 12, 2007, Pages 1252-1256

  Fang, F C ^a   Tzao, C ^a   Cheng, Y L ^a   Chan, D C ^a   Nieh, S ^a   Lee, Shih Chun ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

c kit; Esophagus; Gastrointestinal stromal tumor; Malignant

Indexed keywords

BARIUM; EOSIN; HEMATOXYLIN; IMATINIB;

ADULT; ANAMNESIS; ARTICLE; CANCER RISK; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DYSPHAGIA; ENDOSCOPY; ESOPHAGUS TUMOR; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; MICROSCOPY; MITOSIS INDEX; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; SUBMUCOSA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; BIOPSY; DEGLUTITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, DIGESTIVE SYSTEM; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FROZEN SECTIONS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MITOTIC INDEX; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 38349043868     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963428     Document Type: Article

References (17)

1. Logrono R et al. Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST). Cancer Biol Ther 2004; 3: 251-258
2. Hirota S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580
3. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507-519
4. Lasota J et al. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999; 154: 53-60
5. Blay JY et al. Recommendations for the management of GIST patients. Bull Cancer 2005; 92: 907-918
6. Taniguchi M et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999; 59: 4297-4300
7. Miettinen M, Sarlomo-Rikala J, Lasota J. Gastrointestinal stromal tumours. Ann Chir Gynaecol 1998; 87: 278-281
8. Emory TS et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87
9. Okai T et al. Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor. Abdom Imaging 2003; 28: 301-307
10. van Kouwen MC et al. FDG-PET scanning in the diagnosis of gastrointestinal cancers. Scand J Gastroenterol Suppl 2004; 241: 85-92
11. von Rahden BH et al. Enucleation of submucosal tumors of the esophagus: minimally invasive versus open approach. Surg Endosc 2004; 18: 924-930
12. Ertem M et al. Thoracoscopic enucleation of a giant submucosal tumor of the esophagus. Surg Laparosc Endosc Percutan Tech 2004; 14: 87-90
13. Langer C et al. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003; 90: 332-339
14. Ng EH et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992; 215: 68-77
15. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002; 38 (Suppl 5): S39-S51
16. Fletcher CD et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465
17. Joensuu H et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002; 3: 655-664